Log in or Sign up for Free to view tailored content for your specialty!
Lung Cancer News
Exercise should be standard part of cancer care during treatment, ASCO guideline states
It is well known that obesity, physical inactivity and a poor diet increase the risk for various cancer types and contribute to adverse outcomes among adults with certain malignancies.
Sotorasib delays progression of advanced KRAS-mutant non-small cell lung cancer
Sotorasib significantly extended PFS compared with standard-of-care docetaxel as second-line therapy for patients with KRASG12C-mutated non-small cell lung cancer, data from the randomized phase 3 CodeBreak 200 trial showed.
Log in or Sign up for Free to view tailored content for your specialty!
Healio Minute Podcast, Lung Cancer Edition: Top Headlines - Week of September 12, 2022
In this edition, germline testing ‘should be considered’ for all patients with lung cancer; phase 3 trial of canakinumab misses endpoint; sexual dysfunction common among women with lung cancer, and more.
Particles associated with climate change may cause lung cancer in never-smokers
Exposure to increased concentrations of airborne particulate matter appeared associated with increased risk for EGFR-mutated non-small cell lung cancer among never-smokers, according to study results presented at ESMO Congress.
Statins may provide additional poststroke survival benefit in those with prior cancer
Statin therapy after ischemic stroke is associated with improved survival and may be particularly beneficial in patients with a history of cancer, according to a brief report published in Stroke.
Intensive telephone-based intervention boosted smoking cessation at 3 months
Immediate provision of an intensive telephone-based smoking cessation intervention was associated with increased rates of smoking cessation at 3 months, researchers reported at the European Respiratory Society International Congress.
Novel bispecific T-cell receptor therapy shows early promise in advanced solid tumors
An off-the-shelf T-cell receptor therapy has shown promising early results in multiple solid tumor types, according to initial data from a phase 1 dose-escalation trial presented at ESMO Congress.
VIDEO: ‘Good research’ at lung cancer conference ‘answers some questions,’ creates others
In this video, Hossein Borghaei, DO, MS, discusses safety, response and survival data of patients with small cell lung cancer who received tarlatamab, a half-life extended bispecific T-cell engager, or HLE BiTE.
VIDEO: ‘Fine-tuned’ data from IMpower010 shows OS benefit for subset of patients
At this year’s International Association for the Study of Lung Cancer World Conference on Lung Cancer, one of the more talked about presentations was IMpower010.
Q&A: Biomarker testing opens doors for personalized treatment options in lung cancer
In an interview with Healio, Julia Rotow, MD, spoke about the importance of biomarker testing, the best methods to identify these biomarkers and new advances in personalized treatment options for patients